Warfarin, an anti-clotting drug used since the 1950s, requires patients to have regular testing to monitor its effectiveness and dosage adjustment. According to this most recent update, dabigatran
PRIMACYT Cell Culture Technology GmbH provides in-vitro technology services to the pharmaceutical and biotech industry. It currently offers hepatocyte cells to the drug discovery research community throughout Europe.
The Aeolus contract is valued at $10.4m for the first year and can be extended for a total of five years and up to a total of $118.4m.
The certificate covers sterile liquids, solids, devices and implants manufactured in any of AMP’s eight aseptic suites and ancillary manufacturing suites. AMP is a full service cGMP, FDA,
The new results showed that MDV3100 continues to show durable antitumor activity as evaluated by median times to prostate-specific antigen (PSA) progression and radiographic progression. These findings confirm
The acquisition enables Daiichi Sankyo to leverage existing resources to more cost-effectively supplement its operations rather than build a new facility. The facility is expected to be operational
The LifeNexus Personal Health Card stores comprehensive health information for individuals and their family members on its iChip (the Individually Controlled Health Information Platform) which is encrypted and
Genus Oncology has also filed an investigational new drug (IND) application with the US Food & Drug Administration (FDA). The prospective, open-label Phase I trial is designed to
Veeva Vault will deliver on the promise of deploying a flexible content management system across the entire company, spanning promotional materials management, R&D submissions, quality and manufacturing, and
The NG Class represents a new detergent family based on the maltose-neopentyl amphiphile design, and is more capable than current leading detergents, such as n-dodecyl-ß-D-maltoside (DDM) in speeding
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.